Efficacy and safety of preoperative IOP reduction using a preservative-free fixed combination of dorzolamide/timolol eye drops versus oral acetazolamide and dexamethasone eye drops and assessment of the clinical outcome of trabeculectomy in glaucoma.
INTRODUCTION:To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (Δ = 4 mm Hg) to oral acetazolamide and topical dexamethasone (standard therapy) in terms of intraocular pressure (IOP) reduction 3 and 6 months after trabeculectomy in glaucoma patie...
Main Authors: | Katrin Lorenz, Joanna Wasielica-Poslednik, Katharina Bell, Giulia Renieri, Alexander Keicher, Christian Ruckes, Norbert Pfeiffer, Hagen Thieme |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5310886?pdf=render |
Similar Items
-
Risk factors for periorbital dermatitis in patients using dorzolamide/timolol eye drops
by: Myungjin Kim, et al.
Published: (2021-09-01) -
Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
by: Inoue K, et al.
Published: (2015-04-01) -
NIGHTMARES FROM TOPICAL TIMOLOL EYE DROPS: A CASE REPORT
by: Yousaf Jamal Mahsood, et al.
Published: (2020-09-01) -
Pharmacodynamic equivalence study of two preparations of eye drops, containing dorzolamide in healthy volunteers
by: Gatchev Emil M., et al.
Published: (2016-01-01) -
Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
by: Rakić Danijela, et al.
Published: (2006-01-01)